 ENGLEWOOD, CO ACCESSWIRE September 7, 2021 Aytu BioPharma, Inc. NASDAQ:AYTU, a specialty pharmaceutical company focused on commercializing novel therapeutics and consumer healthcare products, announced today that Josh Disbrow, Chairman and Chief Executive Officer will present during two upcoming investor conferences in September: H. C. Wainwright 23 rd Annual Global Investment Conference: On demand presentation available beginning Monday, September 13, 2021 at 7 a.m. 